It has been postulated that beta-adrenergic stimulation leads to an increase in intracellular cyclic AMP level and induces the relaxation of tracheobronchial smooth muscle, and that alpha-adrenergic stimulation causes bronchoconstriction. The present investigation was conducted to explore the effects of beta-adrenergic receptor stimulators and alpha-adrenergic receptor blocker on plasma cyclic AMP and cyclic GMP contents in healthy volunteers and asthmatic patients.
Various bronchodilators and tolazoline hydrochloride (imidalin), an alpha-adrenergic receptor blocker, were given orally to healthy volunteers and to asthmatic patients, and plasma cyclic AMP and cyclic GMP contents were determined by radioimmunoassay.
1) In healthy volunteers the plasma cyclic AMP content was increased for two hours after oral administration of aminophylline (300mg), and the increase became bigger by combination with imidalin (60mg). There was no significant change in cyclic GMP content.
2) In healthy volunteers the plasma cyclic AMP content was increased for two hours after oral administration of methylephedrine (25mg), and the increase became bigger by combination with imidalin (60mg). However there was no significant change in cyclic GMP content.
3) In healthy volunteers the plasma cyclic AMP content was increased for two hours after oral administration of hexoprenaline sulfate (1.5mg) and salbutamol hemisulfate (6mg), and the increase became bigger by combination with imidalin (60mg), while there was no significant change in cyclic GMP content.
4) In asthmatic patients the plasma cyclic AMP content was increased for two hours after oral administration of salbutamol hemisulfate (6mg), and the increase became bigger by combining imidalin (60mg). However, there was no significant change in cyclic GMP content.
The above results may suggest the effectiveness of administration of alpha-adrenergic receptor blocking agents in asthmatic patients combined with beta-adrenergic receptor stimulators.
View full abstract